| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 54.73▼ | 54.83▼ | 54.83▼ | 55.67▼ | 55.12▼ |
| MA10 | 55.12▼ | 55.34▼ | 55.34▼ | 55.12▼ | 55.38▼ |
| MA20 | 55.51▼ | 55.79▼ | 55.78▼ | 55.24▼ | 60.75▼ |
| MA50 | 55.83▼ | 55.29▼ | 55.17▼ | 55.63▼ | 62.37▼ |
| MA100 | 55.15▼ | 55.25▼ | 55.45▼ | 61.35▼ | 57.52▼ |
| MA200 | 55.34▼ | 54.83▼ | 55.10▼ | 61.63▼ | 55.23▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.141▼ | -0.211▼ | -0.222▼ | 0.133▲ | -0.702▼ |
| RSI | 39.488▼ | 41.764▼ | 42.502▼ | 45.496▼ | 40.429▼ |
| STOCH | 12.374▼ | 12.659▼ | 12.659▼ | 54.897 | 33.070 |
| WILL %R | -76.705▼ | -82.737▼ | -82.737▼ | -69.945 | -77.806▼ |
| CCI | -84.251 | -114.151▼ | -112.971▼ | -76.913 | -63.927 |
|
Saturday, October 20, 2018 11:50 PM
ANI Pharmaceuticals Inc (NASDAQ:ANIP) has received an average recommendation of “Hold” from the six analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has r...
|
|
Tuesday, October 16, 2018 06:00 AM
BAUDETTE, Minn., Oct. 16, 2018 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq:ANIP) today announced the launch of Terbutaline Sulfate Tablets USP, 2.5mg and 5mg, an authorized generic of Br...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/10/18 | 54.565 | 54.69 | 54.28 | 54.69 | 33,186 |
| 19/10/18 | 55.98 | 56.275 | 54.59 | 55.00 | 38,116 |
| 18/10/18 | 56.24 | 57.63 | 55.33 | 55.94 | 50,387 |
| 17/10/18 | 56.13 | 56.79 | 55.02 | 56.44 | 62,000 |
| 16/10/18 | 54.83 | 56.445 | 53.93 | 56.27 | 61,591 |
| 15/10/18 | 54.31 | 55.00 | 53.6074 | 54.57 | 61,065 |
| 12/10/18 | 54.87 | 55.37 | 53.995 | 54.38 | 45,492 |
| 11/10/18 | 54.23 | 55.41 | 53.4267 | 53.98 | 56,852 |
| 10/10/18 | 55.50 | 55.73 | 54.27 | 54.38 | 67,943 |
| 09/10/18 | 54.73 | 56.39 | 54.54 | 55.50 | 69,025 |
|
|
||||
|
|
||||
|
|
||||
|
|